Aurobindo Pharma gets USFDA nod for HIV drug PTI Nov 30, 2023 The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Darunavir…
Aurobindo Pharma’s Managing Director resigns Press Trust of India Oct 4, 2021 N Govindarajan will be relieved from the services of the company effective from the close of business on 31st December, 2021
Aurobindo Pharma plans to launch 50-60 products in US in FY21 Press Trust of India Jun 22, 2020 Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.